These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31426965)
1. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo. Oliveira C; Granja S; Neves NM; Reis RL; Baltazar F; Silva TH; Martins A Carbohydr Polym; 2019 Nov; 223():115034. PubMed ID: 31426965 [TBL] [Abstract][Full Text] [Related]
2. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Koyanagi S; Tanigawa N; Nakagawa H; Soeda S; Shimeno H Biochem Pharmacol; 2003 Jan; 65(2):173-9. PubMed ID: 12504793 [TBL] [Abstract][Full Text] [Related]
3. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo. Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187 [TBL] [Abstract][Full Text] [Related]
4. Effect of Enzymatically Extracted Fucoidans on Angiogenesis and Osteogenesis in Primary Cell Culture Systems Mimicking Bone Tissue Environment. Ohmes J; Xiao Y; Wang F; Mikkelsen MD; Nguyen TT; Schmidt H; Seekamp A; Meyer AS; Fuchs S Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32967359 [TBL] [Abstract][Full Text] [Related]
5. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of fucoidan in anaplastic thyroid cancer via apoptosis and anti-angiogenesis. Shen HY; Li LZ; Xue KC; Hu DD; Gao YJ Mol Med Rep; 2017 May; 15(5):2620-2624. PubMed ID: 28447753 [TBL] [Abstract][Full Text] [Related]
7. Influence of Fucoidan Extracts from Different Fucus Species on Adult Stem Cells and Molecular Mediators in In Vitro Models for Bone Formation and Vascularization. Wang F; Xiao Y; Neupane S; Ptak SH; Römer R; Xiong J; Ohmes J; Seekamp A; Fretté X; Alban S; Fuchs S Mar Drugs; 2021 Mar; 19(4):. PubMed ID: 33805470 [TBL] [Abstract][Full Text] [Related]
8. Fucoidan Derived from Bae H; Lee JY; Yang C; Song G; Lim W Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31936539 [TBL] [Abstract][Full Text] [Related]
9. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. Xue M; Ge Y; Zhang J; Wang Q; Hou L; Liu Y; Sun L; Li Q PLoS One; 2012; 7(8):e43483. PubMed ID: 22916270 [TBL] [Abstract][Full Text] [Related]
10. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027 [TBL] [Abstract][Full Text] [Related]
11. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib. Özcetin A; Aigner A; Bakowsky U Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898 [TBL] [Abstract][Full Text] [Related]
13. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects. Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033 [TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675 [TBL] [Abstract][Full Text] [Related]
15. Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells. Liu F; Wang J; Chang AK; Liu B; Yang L; Li Q; Wang P; Zou X Phytomedicine; 2012 Jun; 19(8-9):797-803. PubMed ID: 22510492 [TBL] [Abstract][Full Text] [Related]
16. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment. Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568 [TBL] [Abstract][Full Text] [Related]
17. Fucoidan inhibits angiogenesis induced by multiple myeloma cells. Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597 [TBL] [Abstract][Full Text] [Related]
18. Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum. Kim KT; Rioux LE; Turgeon SL Phytochemistry; 2014 Feb; 98():27-33. PubMed ID: 24388677 [TBL] [Abstract][Full Text] [Related]
19. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424 [TBL] [Abstract][Full Text] [Related]
20. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1. Lin B; Song X; Yang D; Bai D; Yao Y; Lu N Gene; 2018 May; 654():77-86. PubMed ID: 29454091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]